X0306 5 2018-12-31 0 1 0001653821 CEN BIOTECH INC CENBF 0001736937 Tarrabain Alex 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Chief Financial Officer* Common Stock 2018-01-14 4 J 0 L 3000 0 A 114571 D Common Stock 2018-02-14 4 J 0 L 3000 0 A 114571 D Common Stock 2018-03-15 4 J 0 L 3000 0 A 114571 D Common Stock 2018-04-17 4 J 0 L 3000 0 A 114571 D Common Stock 2018-05-14 4 J 0 L 3000 0 A 114571 D Common Stock 2018-06-15 4 J 0 L 3000 0 A 114571 D Common Stock 2018-07-16 4 J 0 L 3000 0 A 114571 D Common Stock 2018-08-16 4 J 0 L 3000 0 A 114571 D Common Stock 2018-09-16 4 J 0 L 3000 0 A 114571 D Common Stock 2018-10-16 4 J 0 L 3000 0 A 114571 D Common Stock 2018-11-20 4 J 0 L 3000 0 A 114571 D Common Stock 2018-12-14 4 J 0 L 3000 0 A 114571 D 36,000 shares of common stock of the issuer were issued from January 14, 2018 to December 14, 2018 as interest pursuant to agreeing to extend the maturity date of a promissory note which was issued on January 14, 2018 in the amount of $75,000. Includes 30,000 shares issuable upon conversion of a convertible promissory note held by the reporting person which was issued on October 26, 2016 in the amount of $48,000. *On July 12, 2017, Alex Tarrabain (the "Reporting Person") was appointed as a director of the issuer. On May 21, 2019, the Reporting Person was appointed as the Chief Financial Officer of the issuer. /s/ Alex Tarrabain 2021-04-27